跳至主要内容
临床试验/NL-OMON21128
NL-OMON21128尚未招募不适用

A Clinical Study to Evaluate the Clinical Performance of HF10™ SCS Therapy in Failed Back Surgery Syndrome Patients in the Dutch Healthcare System

evro Corp.0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Diagnosed with Failed Back Surgery Syndrome which has been refractory to conservative therapy for a minimum of 3 months and indicated for SCS as per Dutch SCS guidelines and as approved by the Dutch insurance companies
  • 2.Average leg pain intensity of ¡Ý 5 out of 10 cm on the Visual Analog Scale (VAS) at enrollment
  • 3.Average back pain intensity ¡Ü average leg pain intensity on the Visual Analog Scale (VAS) at enrollment
  • 4.An adult (¡Ý 18 years of age) at time of enrollment

排除标准

  • 1.A medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints,
  • 2.Evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcome, as determined by a psychologist
  • 3.A diagnosis of scoliosis that precludes lead placement
  • 4.Radiographic evidence of mechanical spinal instability requiring fusion.
  • 5.Pain that is significantly exacerbated by activity or significantly alleviated by rest
  • 6.Benefitting within 30 days prior to enrollment from an interventional procedure and/or surgery to treat back and/or leg pain
  • 7.Existing drug pump and/or SCS system or another active implantable device such as a pacemaker (switched On or Off)
  • 8.Prior experience with SCS
  • 9.Pregnant

研究者

发起方
evro Corp.

相似试验